Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Nandrolone Overview, Dosing & Safety | Peptide Database

Nandrolone (Deca-Durabolin) Anabolic-Androgenic Steroid | Joint & Collagen Support Community Research Join others researching Nandrolone — share findings, ask questions, and learn from real experiences Nandrolone is a synthetic 19-nortestosterone anabolic-andr

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Nandrolone (Deca-Durabolin)

Anabolic-Androgenic Steroid | Joint & Collagen Support

Community Research

Join others researching Nandrolone — share findings, ask questions, and learn from real experiences

Nandrolone is a synthetic 19-nortestosterone anabolic-androgenic steroid that has been in clinical use since the 1960s. Structurally, it differs from testosterone by the absence of a methyl group at the C19 position, which significantly reduces its androgenic activity relative to its anabolic potency. Nandrolone decanoate (Deca-Durabolin) was FDA-approved for the treatment of anemia associated with chronic renal failure and has also been used clinically for osteoporosis, wasting diseases, and severe burn recovery. Among anabolic steroids, nandrolone is particularly valued for its positive effects on collagen synthesis, joint health, and bone mineral density. It has one of the most favorable anabolic-to-androgenic ratios of any synthetic steroid (approximately 125:37 compared to testosterone at 100:100), making it a frequent choice for individuals seeking muscle growth with reduced androgenic side effects. Nandrolone is available in two primary ester formulations: the long-acting decanoate ester and the shorter-acting phenylpropionate ester (NPP).

Nandrolone binds to the androgen receptor (AR) with affinity comparable to testosterone, promoting nitrogen retention, protein synthesis, and satellite cell activation in skeletal muscle tissue. Its anabolic effects are mediated through AR-dependent gene transcription that upregulates muscle-specific proteins including myosin heavy chain and IGF-1. A key distinguishing feature of nandrolone is its interaction with 5-alpha reductase: unlike testosterone, which is converted to the more potent androgen dihydrotestosterone (DHT), nandrolone is reduced to dihydronandrolone (DHN), a weaker androgen. This results in lower androgenic activity in tissues rich in 5-alpha reductase (skin, prostate, hair follicles). Nandrolone also stimulates collagen synthesis and bone mineral content through direct effects on osteoblasts and fibroblasts, contributing to its well-documented benefits for joint and connective tissue health. It exhibits moderate progestogenic activity, binding to the progesterone receptor at approximately 20% the affinity of progesterone, which can influence prolactin levels and contribute to progesterone-related side effects. Nandrolone aromatizes to estradiol at roughly 20% the rate of testosterone, resulting in lower but not absent estrogenic activity.

Molecular Data

Research Indications

FDA-approved indication. Nandrolone decanoate stimulates erythropoietin production and directly enhances erythropoiesis, increasing red blood cell mass in patients with chronic kidney disease-associated anemia. Used particularly in patients who respond poorly to erythropoiesis-stimulating agents.

Historical use in aplastic anemia to stimulate red blood cell, white blood cell, and platelet production. Largely superseded by modern therapies but still considered in resource-limited settings.

Nandrolone increases collagen synthesis (type I and III), synovial fluid production, and overall connective tissue integrity. Widely reported to reduce joint pain and improve function in individuals with degenerative joint conditions or training-related joint stress. The mechanism involves direct stimulation of fibroblast activity and increased procollagen mRNA expression.

Nandrolone has been studied for the treatment and prevention of osteoporosis, particularly in postmenopausal women and hypogonadal men. It increases bone mineral density through direct osteoblast stimulation and suppression of osteoclast activity.

Used in HIV/AIDS-associated wasting, cancer cachexia, and chronic illness-related sarcopenia to preserve and restore lean body mass. Demonstrated significant improvements in lean mass, strength, and functional capacity in clinical trials.

Dose-dependent increases in lean body mass and muscle cross-sectional area. At therapeutic and supraphysiological doses, nandrolone promotes substantial gains in skeletal muscle with less water retention than equianabolic doses of testosterone.

Increases in maximal strength across compound movements, driven by enhanced protein synthesis, nitrogen retention, and glycogen storage. Effects are dose-dependent and most pronounced when combined with resistance training.

Nandrolone has been used to accelerate recovery from major surgery, severe burns, and debilitating injuries by promoting positive nitrogen balance, collagen deposition, and lean tissue preservation during catabolic states.

Preclinical evidence suggests nandrolone may enhance tendon healing by increasing collagen fiber organization and cross-linking. Clinical applications for tendon repair remain investigational but are supported by its known collagen-stimulating properties.

Dosing Protocols

Nandrolone is administered exclusively via intramuscular injection. Two ester formulations are available: nandrolone decanoate (Deca-Durabolin), a long-acting ester that permits weekly or biweekly dosing, and nandrolone phenylpropionate (NPP), a shorter ester requiring injections every 2-3 days. Decanoate is more common in clinical and performance settings due to its convenient dosing schedule, while NPP is preferred by those who want faster clearance and more rapid dose adjustments.

TRT Adjunct - Joint Support

50-100 mg/week

1x per week (decanoate)

Intramuscular

Therapeutic - Anemia / Wasting

100-200 mg/week

Performance Enhancement - Moderate

200-400 mg/week

1x per week (decanoate) or split into 2 injections

NPP Protocol - Shorter Cycle

200-350 mg/week

Every other day or 3x per week

Reconstitution Instructions

Pre-filled nandrolone vial (typically 100-200 mg/mL in sesame or arachis oil)

Syringes (1 mL or 3 mL)

Drawing needle (18-21 gauge)

Injection needle (22-25 gauge for IM)

Alcohol swabs

Sharps container

1 Wash hands thoroughly and prepare a clean work surface

2 Wipe vial stopper with alcohol swab and allow to dry

3 Draw air into syringe equal to the volume of nandrolone to be withdrawn

4 Insert drawing needle through vial stopper and inject air to equalize pressure

5 Invert vial and withdraw the prescribed dose, tapping to remove air bubbles

6 Switch to injection needle (do not inject with drawing needle)

7 Clean injection site with alcohol swab in circular motion outward

8 Insert needle at 90-degree angle into ventrogluteal, vastus lateralis, or deltoid muscle

9 Aspirate briefly (optional per current guidelines), then inject slowly over 10-30 seconds

10 Withdraw needle, apply gentle pressure with gauze, dispose of needle in sharps container

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Suppression of natural testosterone production (profoundly suppressive, more so than testosterone alone)

Water retention and bloating (less than testosterone at equianabolic doses)

Erectile dysfunction and reduced libido without concurrent testosterone ('deca dick')

Increased appetite and weight gain

Mild acne and oily skin (less pronounced than testosterone)

Elevated hematocrit and hemoglobin (erythrocytosis)

Injection site pain or discomfort

Mild mood changes (some users report increased emotional sensitivity)

Stop Signs - Discontinue if:

Severe chest pain, tightness, or pressure

Sudden shortness of breath or difficulty breathing at rest

Swelling, warmth, or pain in one leg (potential deep vein thrombosis)

Severe or persistent headaches with visual disturbances

Yellowing of skin or eyes (jaundice)

Signs of stroke: sudden numbness, confusion, trouble speaking, loss of coordination

Breast discharge or significant gynecomastia progression

Persistent severe depression or suicidal ideation

Contraindications

Prostate cancer (active or history of hormone-sensitive prostate cancer)

Breast cancer in males or females

Pregnancy or potential for pregnancy (Category X - causes virilization of female fetus)

Nephrosis or the nephrotic phase of nephritis

Severe hepatic impairment

Hypercalcemia

Known hypersensitivity to nandrolone or any formulation components

Polycythemia (hematocrit above 54% at baseline)

Uncontrolled heart failure or severe cardiovascular disease

Quality Checklist

Good Signs

Clear, pale yellow to yellow oil with no visible particles or cloudiness

Pharmaceutical-grade product with valid lot number and manufacturer identification

Proper labeling with concentration (typically 100 or 200 mg/mL), ester type, and expiration date

Intact rubber stopper with no signs of prior puncture

Oil draws smoothly with appropriate viscosity (carrier oils: sesame, arachis/peanut, or castor oil)

Prescribed by licensed physician with documented clinical indication

Warning Signs

Underground lab (UGL) product without pharmaceutical-grade verification

Concentration claims above 300 mg/mL (higher concentrations often cause severe post-injection pain)

Vial label with spelling errors, misaligned printing, or unprofessional appearance

Oil appears slightly darker than expected but is otherwise clear

Product labeled as nandrolone but carrier oil is unidentified

Bad Signs

Cloudy, discolored, or particulate-containing solution (contamination risk)

Crashed product (crystallized steroid visible in vial)

Broken or missing tamper-evident seal on vial

No labeling, incorrect labeling, or missing expiration date

Pain, redness, or swelling at injection site lasting more than 72 hours (potential infection or abscess)

Product sourced without any testing or third-party verification

Allergic reaction at injection site in patients with peanut allergy (arachis oil carrier)

Frequently Asked Questions

Will nandrolone cause erectile dysfunction without testosterone?

Yes, definitively. Running nandrolone without a concurrent testosterone base results in 'deca dick' -- severe erectile dysfunction and loss of libido. This is because nandrolone's reduced metabolite (DHN) displaces DHT in sexual and neurological tissues. A testosterone base at a minimum 1:1 ratio (ideally 2:1 or 3:1) is essential to maintain sexual function and overall quality of life during a nandrolone cycle.

Does finasteride (Propecia) protect against nandrolone hair loss?

No -- finasteride will actually worsen hair loss on nandrolone. Nandrolone is normally reduced by 5-alpha reductase to dihydronandrolone (DHN), which is weaker than the parent compound. Blocking this reduction with finasteride removes the protective conversion and leaves the more androgenic nandrolone parent molecule acting unopposed on hair follicles. If concerned about hair loss on nandrolone, lower the dose instead of adding finasteride.

What's the benefit of nandrolone over testosterone for joints?

Nandrolone has superior collagen synthesis effects -- it directly stimulates type I and III collagen production in tendons and ligaments, improving synovial fluid production and joint lubrication. Testosterone alone doesn't produce this benefit to the same degree. At 50-100 mg/week with testosterone, nandrolone provides meaningful joint relief that many athletes notice within 4-6 weeks.

How long until nandrolone metabolites clear for a drug test?

Nandrolone metabolites are stored in adipose tissue and can be detected for up to 18 months after discontinuation, especially with the long decanoate ester. If you're subject to testing (sports, military, employment), plan accordingly -- this is not a compound that clears from your system quickly. NPP (phenylpropionate) clears faster than decanoate but still persists for weeks.

References

Comprehensive review of nandrolone decanoate's pharmacology and clinical efficacy in osteoporosis, demonstrating significant increases in bone mineral density and reductions in fracture risk. Documented nandrolone's favorable anabolic-to-androgenic ratio and its collagen-stimulating properties.

Case series demonstrating nandrolone decanoate's efficacy in treating erythropoietin-refractory anemia in chronic kidney disease patients. Patients showed significant improvements in hemoglobin levels, supporting nandrolone's FDA-approved indication for renal anemia.

Landmark study establishing dose-dependent anabolic effects of supraphysiological androgens on muscle size and strength. While focused on testosterone, this trial provided the foundational framework for understanding anabolic steroid dose-response relationships applicable to nandrolone.

Review examining the effects of anabolic steroids on tendon structure and function. Found that nandrolone, unlike many other anabolic steroids, may have beneficial effects on collagen synthesis and tendon healing, consistent with its clinical reputation for joint and connective tissue support.

Comprehensive review of nandrolone decanoate covering its clinical applications, mechanisms of action, and side effect profile. Documented the compound's progestogenic activity, its interaction with 5-alpha reductase, and the importance of concurrent testosterone to prevent sexual dysfunction.

Related Peptides

Testosterone base is considered mandatory when running nandrolone. Nandrolone alone causes severe sexual dysfunction ('deca dick') because its reduced metabolite DHN displaces DHT in neurological and sexual tissues. A testosterone-to-nandrolone ratio of at least 1:1 (commonly 2:1 or 3:1) is standard practice to maintain adequate DHT levels for sexual function.

BPC-157 and nandrolone complement each other for joint and connective tissue healing. BPC-157 promotes angiogenesis and growth factor upregulation in injured tissues, while nandrolone enhances collagen synthesis and structural repair. The combination is commonly used for chronic joint issues and tendon recovery.

HCG helps maintain testicular function and endogenous testosterone production during nandrolone use. Since nandrolone is profoundly suppressive of the HPT axis, concurrent HCG (500-1000 IU 2-3x per week) can preserve fertility potential and testicular volume, particularly important for those planning post-cycle recovery.

Aromatase inhibitors can be used to manage estradiol from the concurrent testosterone base. Nandrolone itself aromatizes at about 20% the rate of testosterone, so direct estrogenic contribution is modest. Caution is warranted as over-suppression of estradiol worsens joint symptoms, counteracting one of nandrolone's primary benefits.

Dopamine agonist used to manage prolactin elevations caused by nandrolone's progestogenic activity. Typical dose is 0.25-0.5 mg twice weekly if prolactin rises above reference range. Should only be used when bloodwork confirms elevated prolactin, not prophylactically.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Why is VIP rarely used clinically if research shows such promise?

VIP's extremely short 1-2 minute half-life makes it impractical for routine clinical use - requiring constant infusions or multiple daily injections. Stabilized analogs (like stearyl-Nle17-VIP) are 100-fold more potent but rarely available outside research settings. Limited commercial development has restricted clinical availability despite strong research foundation.

Source: peptide-db.com ↗

Research Indications

LDN has shown benefit across a broad spectrum of autoimmune diseases including Hashimoto's thyroiditis, rheumatoid arthritis, lupus, and multiple sclerosis. The immune-modulating effects via TLR4 antagonism and OGF upregulation help rebalance dysregulated immune responses. Multiple case series and small trials report symptom improvement and reduced inflammatory markers. Several clinical trials have demonstrated benefit in Crohn's disease, with one RCT showing a 67% response rate and 33% remission rate with LDN 4.5 mg versus placebo. Improvements in mucosal healing and quality of life scores have been reported. Preliminary data in ulcerative colitis are also encouraging. Observational studies and small trials suggest LDN may improve quality of life, reduce fatigue, and modestly decrease relapse rates in MS patients. A pilot trial showed improvements in mental health quality of life scores. LDN is often used as adjunctive therapy alongside disease-modifying treatments. Two randomized controlled trials have demonstrated that LDN (4.5 mg) significantly reduces pain severity (approximately 30% reduction from baseline), improves overall satisfaction with life, and enhances mood in fibromyalgia patients. Responders showed greater reductions in inflammatory markers including ESR. Anecdotal reports and small observational studies suggest LDN may reduce fatigue severity and improve functional capacity in ME/CFS patients. The anti-neuroinflammatory mechanism via TLR4 antagonism on microglia is a plausible pathway. Larger controlled trials are needed. Case reports and small case series document meaningful pain reduction and functional improvement with LDN in CRPS patients. The combination of anti-neuroinflammatory and endorphin-enhancing effects makes LDN a plausible adjunctive therapy for this difficult-to-treat condition. By upregulating endogenous endorphins and modulating the opioid reward system, LDN may address anhedonia (inability to feel pleasure) - a symptom poorly addressed by conventional antidepressants. Preliminary studies and clinical experience suggest benefits for mood and motivation, particularly in patients with inflammation-driven depression.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Available in capsule form for oral administration. Short peptides can be absorbed orally and reach target tissues. Typical protocol involves 10-20 day cycles. Standard protocol 10-20 mg Daily for 10-20 days Oral capsules Maintenance 10 mg 2-3 cycles yearly

Source: peptide-db.com ↗
Side effects

Common Side Effects

Peeling and flaking (retinoid dermatitis), especially in the first 2-6 weeks Erythema (redness) and skin irritation at the application site Dryness and tightness of the skin Increased photosensitivity (heightened susceptibility to sunburn) Initial acne purging (transient worsening of breakouts in weeks 2-6)

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →